Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity
索拉非尼与贝伐单抗联合靶向治疗可增强毒性和抗肿瘤活性
期刊:Journal of Clinical Oncology
影响因子:42.1
doi:10.1200/JCO.2007.10.8332
Nilofer S Azad, Edwin M Posadas, Virginia E Kwitkowski, Seth M Steinberg, Lokesh Jain, Christina M Annunziata, Lori Minasian, Gisele Sarosy, Herbert L Kotz, Ahalya Premkumar, Liang Cao, Deborah McNally, Catherine Chow, Helen X Chen, John J Wright, William D Figg, Elise C Kohn